Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
9.13
+0.15 (1.67%)
At close: Mar 4, 2026, 4:00 PM EST
8.57
-0.56 (-6.13%)
Pre-market: Mar 5, 2026, 6:37 AM EST
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cross Country Healthcare stock have an average target of 12.87, with a low estimate of 9.00 and a high estimate of 18.61. The average target predicts an increase of 40.96% from the current stock price of 9.13.
Analyst Consensus: Hold
* Price targets were last updated on Feb 3, 2026.
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 3 | 3 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Initiates $11 | Hold | Initiates | $11 | +20.48% | Feb 3, 2026 |
| UBS | UBS | Hold Maintains $17 → $9 | Hold | Maintains | $17 → $9 | -1.42% | Dec 9, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +103.83% | Jun 17, 2025 |
| UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +80.72% | May 13, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +103.83% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
1.09B
from 1.34B
Decreased by -18.68%
Revenue Next Year
1.03B
from 1.09B
Decreased by -5.40%
EPS This Year
0.11
from -0.44
EPS Next Year
0.10
from 0.11
Decreased by -7.37%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.1B | 1.1B | |
| Avg | 1.1B | 1.0B | |
| Low | 1.0B | 965.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.6% | 3.1% | |
| Avg | -18.7% | -5.4% | |
| Low | -22.4% | -11.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.14 | 0.34 | |
| Avg | 0.11 | 0.10 | |
| Low | 0.08 | -0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 218.8% | |
| Avg | - | -7.4% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.